. Author manuscript; available in PMC: 2013 Jun 1.

Published in final edited form as: J Immunol. 2012 Apr 20;188(11):5257–5266. doi: 10.4049/jimmunol.1101934

Table I.

Numbers of Bone Marrow B cell subsets during acute and chronic SCI^a

		Total Cells	Pro/Pre B	Immature B

	Un-injured^b	37.3±7.6	2.47±1.23	0.76±0.43

Day 8 Post Injury^c	T9-Lam	38.03±8.7	1.06±0.29^*	0.18±0.05^*
	T9-SCI	46.32±8.88^*	1.07±0.95^*	0.28±0.37^*
	T3-Lam	46.05±5.6^*	1.85±0.35	0.43±0.13
	T3-SCI	47.97±9.49^*	0.68±0.83^*,^#	0.17±0.17^*

Day 28 Post Injury^d	T9-Lam	34.61±4.42	2.32±0.6	0.84±0.25
	T9-SCI	47.39±9.56^*,^#	2.78±0.92	0.88±0.32
	T3-Lam	36.5±5.47	2.54±0.44	0.95±0.14
	T3-SCI	52.83±9.7^*,^#	2.51±0.98	0.81±0.23

Mean ± SD of cells (×10⁶) per hind limb, gated according to representative FACS plots shown in Fig. 1. Data has been pooled across 6 experiments for un-injured controls, 1 for laminectomies, and 3 for SCI at each level.

n=25 for Un-injured.

n=8 for T9-Lam, n=13 for T9-SCI, n=8 for T3-Lam and n=12 for T3-SCI.

n=6 for T9-Lam, n=13 for T9-SCI, n=7 for T3-Lam and n=13 for T3-SCI.

Denotes significant difference from un-injured control at p<0.05

Denotes significant difference from respective laminectomy control at p<0.05